NSC |
Compound |
Enrichment |
Correlation |
NSC 639517 |
Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.0361455178924429 |
0.43721002 |
NSC 669145 |
2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- |
0.0361455178924429 |
0.48366171 |
NSC 675223 |
1H-1,2,4-Triazole-5(4H)-one, 4-[[(4-nitrophenyl)methylene] amino]-3-phenyl- |
0.0361455178924429 |
-0.3273057 |
NSC 695323 |
Null |
0.0361455178924429 |
0.43354478 |
NSC 113951 |
6-Bromotoyocamycin |
0.0376362543535812 |
0.50305067 |
NSC 135371 |
Null |
0.0376362543535812 |
0.50163888 |
NSC 294526 |
Null |
0.0376362543535812 |
0.34731924 |
NSC 294734 |
7-Oxabicyclo[4.1.0]hept-3-ene-2,5-dione, 3-hydroxy-4-methyl-, (1R-cis)- |
0.0376362543535812 |
0.28559316 |
NSC 351078 |
Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide |
0.0376362543535812 |
0.3944045 |
NSC 354671 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide |
0.0376362543535812 |
0.36538756 |